| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 15 Apr 2025 | 15 Apr 2025 |
| Intimation of Appointment of Company Secretary and compliance officer of the company. | ||
| Board Meeting | 3 Feb 2025 | 23 Jan 2025 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended on 31st December 2024 Unaudited standalone and consolidated Financial Results for the Quarter and nine months ended on 31st December,2024 (As Per BSE Announcement Dated on: 03/02/2025) | ||
| Board Meeting | 29 Oct 2024 | 19 Oct 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve Intimation of Board meeting scheduled on 29th October 2024 to consider the unaudited Financial Result for quarter ended on 30th Sept. 2024 Financial Result for half year ended on 30th September, 2024 Intimation of Allotment of Equity shares 29th Oct, 24 and and re appointment of Mr. Bharat R. Desai, MD (As Per BSE Announcement dated on 29.10.2024) | ||
| Board Meeting | 31 Aug 2024 | 31 Aug 2024 |
| Intimation for appointment of Statutory Auditor | ||
| Board Meeting | 8 Aug 2024 | 31 Jul 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve Intimation of Board Meeting to be scheduled on 8th August 2024 for considering and approve unaudited Financial Result for Quarter Ended on 30th June 2024 Intimation of outcome of Board meeting for Standalone & consolidated Financial Result for quarter ended on 30th June, 2024. (As per BSE Announcement Dated on 08/08/2024) Intimation of Resignation of Statutory Auditor dated 10th August, 2024 (As Per BSE Announcement Dated on 10.08.2024) | ||
| Board Meeting | 10 Jun 2024 | 6 Jun 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2024 inter alia to consider and approve Intimation of Board Meeting Scheduled on 10th June 2024 in continuation of intimation filed dated 05th June 2024 for Allotment of Equity shares on Preferential Basis against Acquisition of Equity stake in Varenyam Healtcare Pvt & Varenyem Biolifesciences Pvt Ltd. Outcome of Board meeting held on 10th June, 2024 (As Per BSE Announcement Dated on: 10/06/2024) | ||
| Board Meeting | 5 Jun 2024 | 26 May 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2024 inter alia to consider and approve Intimation of Board Meeting as Scheduled on 5th June 2024 Intimation of Allotment of Equity Shares on Preferential Basis (As Per BSE Announcement Dated on:05/06/2024) | ||
| Board Meeting | 22 May 2024 | 10 May 2024 |
| Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2024 inter alia to consider and approve To Consider and approve Audited Financial Resut (Standalone & Consolidated) of the company for Year ended on 31st March 2024 and quarterly result and other matters as may be approved by the chairman of the meeting Intimation of Board Meeting Scheduled on 22nd May, 2024 to consider and recommend Final Dividend for Financial Year ended on 31st March, 2024. (As Per BSE Announcement dated on 11.05.2024) Declaration of Financial Result for Quarter and Financial year ended on 31.03.2024 (As Per BSE Announcement Dated on 22.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
